Oxidizability of low-density lipoproteins from Neoral and tacrolimus-treated renal transplant patients.
Renal Research Laboratory, Royal Free Hospital School of Medicine, London, UK.
Z
Z
Varghese
R L
RL
Fernando
G
G
Turakhia
E
E
Psimenou
C
C
Brunton
O N
ON
Fernando
A
A
Davenport
A
A
Burns
P
P
Sweny
S H
SH
Powis
J F
JF
Moorhead
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000975:Antioxidants / Q000032:analysis; D001379:Azathioprine / Q000627:therapeutic use; D002784:Cholesterol / Q000097:blood; D003401:Creatine / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D007700:Kinetics; D008077:Lipoproteins, LDL / Q000097:blood* / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D016559:Tacrolimus / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood; D014508:Urea / Q000097:blood
D000305:Adrenal Cortex Hormones; D000975:Antioxidants; D007166:Immunosuppressive Agents; D008077:Lipoproteins, LDL; D014280:Triglycerides; C099252:oxidized low density lipoprotein; D016572:Cyclosporine; D014508:Urea; D002784:Cholesterol; D001379:Azathioprine; D003401:Creatine; D016559:Tacrolimus